Prognostic factors of hemorrhagic complications after oxaliplatin-based hyperthermic intraperitoneal chemotherapy: Toward routine preoperative dosage of Von Willebrand factor?
Fiche publication
Date publication
février 2017
Journal
European journal of surgical oncology : the journal of the European Society of Surgical Oncology and the British Association of Surgical Oncology
Auteurs
Membres identifiés du Cancéropôle Est :
Dr GROSS Isabelle, Pr ROHR Serge, Dr ROMAIN Benoit, Pr BRIGAND Cécile
Tous les auteurs :
Delhorme JB, Sattler L, Severac F, Triki E, Gross I, Romain B, Rohr S, Grunebaum L, Brigand C
Lien Pubmed
Résumé
Oxaliplatin-based hyperthermic intraperitoneal chemotherapy (HIPEC-ox) induces specific morbidity with hemorrhagic complications (HC). The aim of this study was to identify preoperative, intraoperative and postoperative HC predictive factors after HIPEC-ox.
Mots clés
Chemotherapy, HIPEC, Hemorrhagic complication, Oxaliplatin, Von Willebrand factor
Référence
Eur J Surg Oncol. 2017 Feb;: